These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 22246337)
1. Biologic tumor behavior in pilocytic astrocytomas. Belirgen M; Berrak SG; Ozdag H; Bozkurt SU; Eksioglu-Demiralp E; Ozek MM Childs Nerv Syst; 2012 Mar; 28(3):375-89. PubMed ID: 22246337 [TBL] [Abstract][Full Text] [Related]
2. Pilocytic astrocytomas do not show most of the genetic changes commonly seen in diffuse astrocytomas. Cheng Y; Pang JC; Ng HK; Ding M; Zhang SF; Zheng J; Liu DG; Poon WS Histopathology; 2000 Nov; 37(5):437-44. PubMed ID: 11119125 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathological features and global genomic copy number alterations of pilomyxoid astrocytoma in the hypothalamus/optic pathway: comparative analysis with pilocytic astrocytoma using array-based comparative genomic hybridization. Jeon YK; Cheon JE; Kim SK; Wang KC; Cho BK; Park SH Mod Pathol; 2008 Nov; 21(11):1345-56. PubMed ID: 18622384 [TBL] [Abstract][Full Text] [Related]
4. Genetic aberrations leading to MAPK pathway activation mediate oncogene-induced senescence in sporadic pilocytic astrocytomas. Jacob K; Quang-Khuong DA; Jones DT; Witt H; Lambert S; Albrecht S; Witt O; Vezina C; Shirinian M; Faury D; Garami M; Hauser P; Klekner A; Bognar L; Farmer JP; Montes JL; Atkinson J; Hawkins C; Korshunov A; Collins VP; Pfister SM; Tabori U; Jabado N Clin Cancer Res; 2011 Jul; 17(14):4650-60. PubMed ID: 21610151 [TBL] [Abstract][Full Text] [Related]
5. Association of molecular alterations, including BRAF, with biology and outcome in pilocytic astrocytomas. Horbinski C; Hamilton RL; Nikiforov Y; Pollack IF Acta Neuropathol; 2010 May; 119(5):641-9. PubMed ID: 20044755 [TBL] [Abstract][Full Text] [Related]
6. Expression of retinoblastoma gene product and p21 (WAF1/Cip 1) protein in gliomas: correlations with proliferation markers, p53 expression and survival. Korkolopoulou P; Kouzelis K; Christodoulou P; Papanikolaou A; Thomas-Tsagli E Acta Neuropathol; 1998 Jun; 95(6):617-24. PubMed ID: 9650754 [TBL] [Abstract][Full Text] [Related]
7. Impact of morphology, MIB-1, p53 and MGMT on outcome in pilocytic astrocytomas. Horbinski C; Hamilton RL; Lovell C; Burnham J; Pollack IF Brain Pathol; 2010 May; 20(3):581-8. PubMed ID: 19832838 [TBL] [Abstract][Full Text] [Related]
8. Detection of genetic alterations in gastric cancer patients from Saudi Arabia using comparative genomic hybridization (CGH). Bibi F; Ali I; Naseer MI; Ali Mohamoud HS; Yasir M; Alvi SA; Jiman-Fatani AA; Sawan A; Azhar EI PLoS One; 2018; 13(9):e0202576. PubMed ID: 30212456 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of the expression of tumor suppressor genes p53, p21, p16 and prb, and Ki-67 labelling in high grade astrocytomas treated with radiotherapy. Kirla R; Salminen E; Huhtala S; Nuutinen J; Talve L; Haapasalo H; Kalimo H J Neurooncol; 2000; 46(1):71-80. PubMed ID: 10896207 [TBL] [Abstract][Full Text] [Related]
11. Genomic analysis of pilocytic astrocytomas at 0.97 Mb resolution shows an increasing tendency toward chromosomal copy number change with age. Jones DT; Ichimura K; Liu L; Pearson DM; Plant K; Collins VP J Neuropathol Exp Neurol; 2006 Nov; 65(11):1049-58. PubMed ID: 17086101 [TBL] [Abstract][Full Text] [Related]
12. Study of the MIB-1 labeling index as a predictor of tumor progression in pilocytic astrocytomas in children and adolescents. Bowers DC; Gargan L; Kapur P; Reisch JS; Mulne AF; Shapiro KN; Elterman RD; Winick NJ; Margraf LR J Clin Oncol; 2003 Aug; 21(15):2968-73. PubMed ID: 12885817 [TBL] [Abstract][Full Text] [Related]
13. Simultaneous alterations of retinoblastoma and p53 protein expression in astrocytic tumors. Rathore A; Kamarajan P; Mathur M; Sinha S; Sarkar C Pathol Oncol Res; 1999; 5(1):21-7. PubMed ID: 10079373 [TBL] [Abstract][Full Text] [Related]
14. The expression of cell cycle regulatory proteins in oligodendroglial tumors. Kamiya M; Nakazato Y Clin Neuropathol; 2002; 21(2):52-65. PubMed ID: 12005253 [TBL] [Abstract][Full Text] [Related]
15. Genetic heterogeneity in human astrocytomas: spatial distribution of P16 and TP53 deletions in biopsies. Steilen-Gimbel H; Steudel WI; Feiden W; Moringlane JR; Henn W; Zang KD Cancer Genet Cytogenet; 1999 Sep; 113(2):115-9. PubMed ID: 10484976 [TBL] [Abstract][Full Text] [Related]
16. Outcome analysis of childhood pilocytic astrocytomas: a retrospective study of 148 cases at a single institution. Colin C; Padovani L; Chappé C; Mercurio S; Scavarda D; Loundou A; Frassineti F; André N; Bouvier C; Korshunov A; Lena G; Figarella-Branger D Neuropathol Appl Neurobiol; 2013 Oct; 39(6):693-705. PubMed ID: 23278243 [TBL] [Abstract][Full Text] [Related]
18. Identification of De Novo and Rare Inherited Copy Number Variants in Children with Syndromic Congenital Heart Defects. Hussein IR; Bader RS; Chaudhary AG; Bassiouni R; Alquaiti M; Ashgan F; Schulten HJ; Al Qahtani MH Pediatr Cardiol; 2018 Jun; 39(5):924-940. PubMed ID: 29541814 [TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 and MIB-1 immunohistochemistry in pilocytic astrocytomas: a study of 48 cases. Machen SK; Prayson RA Hum Pathol; 1998 Dec; 29(12):1511-6. PubMed ID: 9865840 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA profile of pediatric pilocytic astrocytomas identifies two tumor-specific signatures when compared to non-neoplastic white matter. Darrigo Júnior LG; Lira RCP; Fedatto PF; Marco Antonio DS; Valera ET; Aguiar S; Yunes JA; Brandalise SR; Neder L; Saggioro FP; Becker AP; de Oliveira RS; Machado HR; Panepucci RA; Tone LG; Scrideli CA J Neurooncol; 2019 Jan; 141(2):373-382. PubMed ID: 30570705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]